Literature DB >> 24672135

Comparison of different doses of vancomycin andteicoplanin lock solutions in catheters colonized with Staphylococcus epidermidis: An in vitro, blinded, antibiotic lock study.

Serkan Oncu1, Serhan Sakarya1.   

Abstract

BACKGROUND: The antibiotic lock (AL) technique is used for sterilization ofthe intraluminal surface of catheters. This technique consists of filling a catheter lumen with an antibiotic solution and allowing it to dwell for a time sufficient to sterilize the device. Glycopeptide antibiotics (vancomycin and teicoplanin) are commonly used agents for this purpose. But studies evaluating the different dosages of these antibiotics, their optimum concentrations, and duration in AL treatment are lacking.
OBJECTIVE: The aim of this study was to compare the efficacy of differentdoses of vancomycin/saline solution (VSS) and teicoplanin/saline solution (TSS) and to establish the optimal dosage and time needed to eliminate intraluminal methicillin-resistant Staphylococcus epidermidis colonization.
METHODS: This in vitro AL study was conducted at the Department of Infectious Diseases and Clinical Microbiology, Adnan Menderes University Medical Faculty, Aydin, Turkey. Catheters were divided into 2 groups those colonized with slime-forming S epidermidis, and those colonized with non-slime-forming S epidermidis. In each group, catheters were locked with VSS or TSS at 1-, 3-, and 5-mg/mL doses. Catheters instilled with saline solution were used as the control group. After 12 hours of incubation, the catheters were drained and filled with human plasma. Instillation of human plasma or AL solution was alternated every 12 hours to simulate clinical conditions. Every other day, catheters locked with each antibiotic dose or saline were cultured to determine colony count. These procedures were maintained until the catheters were sterile.
RESULTS: The baseline counts of slime-forming and non-slime-forming S epidermidisadhered to 1-cm segment catheters were 39 × 106 and 32 × 106 colony-forming units, respectively. The bacterial count was decreased significantly from baseline on the first day after the start of treatment (day 1) (P < 0.001). At the end of day 7, all catheters treated with antibiotics were sterile. The de creases in bacterial count were statistically similar in catheters treated with all doses of VSS and TSS. Also, the decrease in intraluminal colonization was statistically similar in catheters colonized with slime-forming S epidermidis and non-slime-forming S epidermidis.
CONCLUSION: In this in vitro, blinded AL study, the efficacy of vancomycin and teicoplanin lock solutions were similar and sterilized the catheters in 7 days, suggesting that the 2 antibiotics might be selected for shorter durations compared with those currently recommended for AL treatment in catheter-related infections due to methicillin-resistant staphylococci.

Entities:  

Keywords:  antibiotic lock; catheter; teicoplanin; vancomycin

Year:  2005        PMID: 24672135      PMCID: PMC3964565          DOI: 10.1016/j.curtheres.2005.08.008

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


  40 in total

1.  An in vitro evaluation of the antibiotic/heparin lock to sterilize central venous haemodialysis catheters.

Authors:  Lavern M Vercaigne; Sheryl A Zelenitsky; Ian Findlay; Keevin Bernstein; S Brian Penner
Journal:  J Antimicrob Chemother       Date:  2002-04       Impact factor: 5.790

Review 2.  Catheter-related infections: diagnosis and intravascular treatment.

Authors:  E Bouza; A Burillo; P Muñoz
Journal:  Clin Microbiol Infect       Date:  2002-05       Impact factor: 8.067

3.  Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique.

Authors:  Y Haimi-Cohen; N Husain; J Meenan; G Karayalcin; M Lehrer; L G Rubin
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation.

Authors:  A Toledo-Arana; J Valle; C Solano; M J Arrizubieta; C Cucarella; M Lamata; B Amorena; J Leiva; J R Penadés; I Lasa
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

5.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

6.  Growth-rate-independent killing by ciprofloxacin of biofilm-derived Staphylococcus epidermidis; evidence for cell-cycle dependency.

Authors:  I G Duguid; E Evans; M R Brown; P Gilbert
Journal:  J Antimicrob Chemother       Date:  1992-12       Impact factor: 5.790

7.  Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin.

Authors:  I G Duguid; E Evans; M R Brown; P Gilbert
Journal:  J Antimicrob Chemother       Date:  1992-12       Impact factor: 5.790

8.  Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci.

Authors:  A G Gristina; R A Jennings; P T Naylor; Q N Myrvik; L X Webb
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

9.  Treatment of Hickman catheter sepsis using antibiotic lock technique.

Authors:  E A Krzywda; D A Andris; C E Edmiston; E J Quebbeman
Journal:  Infect Control Hosp Epidemiol       Date:  1995-10       Impact factor: 3.254

10.  Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.

Authors:  H Anwar; J L Strap; K Chen; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

View more
  1 in total

1.  In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.

Authors:  Diego Parra; Alejandro Peña-Monje; Nieves María Coronado-Álvarez; José Hernández-Quero; Jorge Parra-Ruiz
Journal:  BMC Microbiol       Date:  2015-10-30       Impact factor: 3.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.